Document is current

Any future updates will be listed below

Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/bmt.2016.338

Published Online: 2016-12-19

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark